Zoom Testing – UK Drug Testing Weekly – 9 January 2026

Welcome to this week’s digest of drug testing news from across the UK and beyond. Each week, we monitor developments in substance use, policy changes, and testing innovations that matter to employers, parents, and testing professionals. This week’s roundup includes the government’s landmark road safety strategy consultation, an alarming surge in ketamine use among schoolchildren, and warnings about deadly synthetic opioids reaching UK shores. Here’s what you need to know.

Road Safety Overhaul Targets Drink and Drug Driving

The government’s new Road Safety Strategy represents the most significant shake-up in decades. With one in six road fatalities in 2023 involving drink driving, ministers are consulting on lowering the legal limit in England and Wales – unchanged since 1967 and currently the highest in Europe. More relevant for employers with vehicle fleets: new powers could allow immediate suspension of driving licences for those suspected of drink or drug driving, even before conviction.

The strategy also explores preventative technology like alcohol interlock devices. For companies operating commercial vehicles, these developments signal a tightening regulatory environment where pre-employment and random testing programmes become increasingly essential risk management tools. The consultation on drink-drive limits represents the first policy change since 1967, bringing England and Wales in line with Scotland and much of Europe.

Ketamine Crisis Escalates in Schools

Data from Halton Borough Council reveals an alarming surge in ketamine-related school exclusions. In the 2024/25 school year, 24 students were suspended and 12 permanently excluded for ketamine use – a dramatic jump from just three incidents the previous year. This isn’t an isolated regional problem. Schools nationwide report teenagers in hospital, thousands spent on vape and drug detectors, and students hiding in toilets to use.

The workplace implications are clear: today’s school-age ketamine users become tomorrow’s workforce. Companies should prepare for increased prevalence of this substance in drug testing programmes, particularly in sectors employing younger workers. As one education expert noted in the BBC’s investigation into school vaping, institutions face a “lonely battle” without adequate resources and support.

Synthetic Opioids: An Unprecedented Threat

Northern Ireland’s senior coroner issued a stark warning about nitazenes, stating there are “no known side effects other than death”. An inquest found that a Dungannon man died from a cocktail of five drugs including these synthetic opioids, which possess a level of strength and danger previously unseen in the region.

Standard workplace drug tests don’t always detect newer synthetic substances. As these compounds spread beyond Northern Ireland, employers in safety-critical industries should discuss expanded testing panels with their providers to capture emerging threats. For context on traditional opioid testing, Talk to Frank provides comprehensive information on opioid risks and harm reduction.

Vaping Dominates Public Health Agenda

Vaping now exceeds traditional smoking prevalence, creating complex challenges. While safer than smoking, reports reveal people struggling to quit e-cigarettes, with some users – particularly 12-year-olds – developing regular habits. Guernsey’s incoming ban on disposable vapes (31 January) and licensing scheme for sellers (31 March) may presage broader UK restrictions.

For workplaces, the rise of vaping among younger employees requires clear policies. While nicotine detection through cotinine testing remains available, most employers focus on substances directly impairing workplace safety rather than nicotine use itself.

Regional Drug Trends and Treatment Insights

Several stories this week highlighted the importance of context when interpreting drug statistics. Tony D’Agostino’s analysis of “Ketamine Deaths Up Twenty-Fold” cautioned against headline-driven policy responses without understanding who is actually dying and why. Similarly, research from British Columbia examining police interactions with harm reduction services underscores how enforcement approaches affect public health outcomes.

For employers, this reinforces the need for balanced drug policies. Testing should protect workplace safety whilst supporting employees who seek help for substance issues. US research showing longer medication-assisted treatment for opioid use disorder improves survival rates for at least four years demonstrates the value of sustained support over punitive-only approaches.

Cannabis Manufacturing Dangers

Tragically, the parents of a seven-year-old killed in a house explosion are now campaigning to warn about dangers from cannabis manufacturing. The rise of domestic production, whether for personal use or commercial operations, creates risks beyond the substances themselves – including electrical fires, structural damage, and violent crime.

International Developments

Across the Atlantic, the Trump administration abandoned long-standing guidance limiting alcohol to 1-2 drinks daily, instead simply advising Americans to “consume less to be healthier.” The Senate also confirmed Sara Carter as “drug czar” despite concerns about amplifying fentanyl misinformation. Meanwhile, Canadian reports found illegal drugs openly advertised on social media and delivered via postal service.

What Employers Should Do

This week’s developments point to several practical actions:

First, review your drug and alcohol policy against the evolving threat landscape. Standard panels may miss synthetic opioids and newer designer drugs. Consider whether your testing programme adequately covers substances prevalent in your region and workforce demographic.

Second, prepare for stricter drink-driving enforcement. If you operate vehicle fleets, ensure policies clearly state expectations for both on-duty and off-duty conduct that could affect driving privileges.

Third, don’t overlook education. With ketamine use surging among school-age populations, younger workers may lack awareness of risks. Brief, fact-based information during induction can establish expectations without being heavy-handed.

Finally, ensure your testing provider uses current methodologies. As new synthetic substances emerge, detection capabilities must keep pace.

---

---

You May Also Like: